Large-scale testing (Phase 3)Active Not RecruitingNCT05147220
What this trial is testing
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)
Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 1,000